{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:54:14Z","timestamp":1790834054426,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,25]],"date-time":"2014-05-25T00:00:00Z","timestamp":1400976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-370","type":"journal-article","created":{"date-parts":[[2014,5,25]],"date-time":"2014-05-25T01:01:51Z","timestamp":1400979711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K\/Akt signaling pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Pengfei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmiao","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,25]]},"reference":[{"key":"4629_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90.","journal-title":"CA Cancer J Clin"},{"key":"4629_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/annonc\/mdr398","volume":"23","author":"D Aune","year":"2012","unstructured":"Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro RDA, Cade JE, Burley VJ, Norat T: Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012, 23: 843-852.","journal-title":"Ann Oncol"},{"key":"4629_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","volume":"23","author":"L Moretta","year":"2004","unstructured":"Moretta L, Moretta A: Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004, 23: 255-259.","journal-title":"EMBO J"},{"key":"4629_CR4","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1182\/blood-2011-11-389924","volume":"119","author":"SS Somanchi","year":"2012","unstructured":"Somanchi SS, Somanchi A, Cooper LJ, Lee DA: Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7. Blood. 2012, 119: 5164-5172.","journal-title":"Blood"},{"key":"4629_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/sj.leu.2404862","volume":"21","author":"N Kato","year":"2007","unstructured":"Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, Imamura M: Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia. 2007, 21: 2103-2108.","journal-title":"Leukemia"},{"key":"4629_CR6","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/eji.201142179","volume":"42","author":"M Balsamo","year":"2012","unstructured":"Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, Lonardi S, Augugliaro R, Moretta A, Facchetti F, Moretta L, Mingari MC, Vitale M: Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol. 2012, 42: 1833-1842.","journal-title":"Eur J Immunol"},{"key":"4629_CR7","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1158\/0008-5472.CAN-08-0054","volume":"68","author":"DR Siemens","year":"2008","unstructured":"Siemens DR, Hu N, Sheikhi AK, Chung E, Frederiksen LJ, Pross H, Graham CH: Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide. Cancer Res. 2008, 68: 4746-4753.","journal-title":"Cancer Res"},{"key":"4629_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/med.10017","volume":"22","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA, Cinatl J: Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev. 2002, 22: 492-511.","journal-title":"Med Res Rev"},{"key":"4629_CR9","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo CF, Nervi C, Pelicci PG, Heinzel T: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001, 20: 6969-6978.","journal-title":"EMBO J"},{"key":"4629_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"CM Das","year":"2007","unstructured":"Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V: Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neurooncol. 2007, 85: 159-170.","journal-title":"J Neurooncol"},{"key":"4629_CR11","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/sj.bjc.6603777","volume":"96","author":"RA Blaheta","year":"2007","unstructured":"Blaheta RA, Michaelis M, Natsheh I, Hasenberg C, Weich E, Relja B, Jonas D, Doerr HW, Cinatl J: Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium. Br J Cancer. 2007, 96: 1699-1706.","journal-title":"Br J Cancer"},{"key":"4629_CR12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-05-0194","volume":"4","author":"DC Marchion","year":"2005","unstructured":"Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN: In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates. Mol Cancer Ther. 2005, 4: 1993-2000.","journal-title":"Mol Cancer Ther"},{"key":"4629_CR13","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-06-0887","volume":"66","author":"X Huang","year":"2006","unstructured":"Huang X, Guo B: Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res. 2006, 66: 9245-9251.","journal-title":"Cancer Res"},{"key":"4629_CR14","first-page":"227","volume":"15","author":"M Schuchmann","year":"2006","unstructured":"Schuchmann M, Schulze-Bergkamen H, Fleischer B, Schattenberg JM, Siebler J, Weinmann A, Teufel A, Worns M, Fischer T, Strand S, Lohse AW, Galle PR: Histone deacetylase inhibition by valproic acid down-regulates c-FLIP\/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. Oncol Rep. 2006, 15: 227-230.","journal-title":"Oncol Rep"},{"key":"4629_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1349-7006.2009.01439.x","volume":"101","author":"X Lu","year":"2010","unstructured":"Lu X, Ohata K, Kondo Y, Espinoza JL, Qi Z, Nakao S: Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis. Cancer Sci. 2010, 101: 609-615.","journal-title":"Cancer Sci"},{"key":"4629_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/leu.2008.354","volume":"23","author":"A Poggi","year":"2009","unstructured":"Poggi A, Catellani S, Garuti A, Pierri I, Gobbi M, Zocchi MR: Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias byall-trans-retinoic acid or sodium valproate. Leukemia. 2009, 23: 641-648.","journal-title":"Leukemia"},{"key":"4629_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1593\/neo.121236","volume":"14","author":"X Wu","year":"2012","unstructured":"Wu X, Tao Y, Hou J, Meng X, Shi J: Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cellmediated Lysis of Myeloma. Neoplasia. 2012, 14: 1178-1189.","journal-title":"Neoplasia"},{"key":"4629_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2007.01.013","volume":"18","author":"NW Zwirner","year":"2007","unstructured":"Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE: Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system. Cytokine Growth Factor Rev. 2007, 18: 159-170.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4629_CR19","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","volume":"65","author":"S Armeanu","year":"2005","unstructured":"Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR: Natural killer cell-mediated lysis of hepatoma cells via specific induction ofNKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 2005, 65: 6321-6329.","journal-title":"Cancer Res"},{"key":"4629_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/hum.2012.143","volume":"24","author":"DG Song","year":"2013","unstructured":"Song DG, Ye Q, Santoro S, Fang C, Best A, Powell DJ: Chimeric NKG2D CARexpressing T cell-mediated attack of human ovarian cancer isenhanced by histone deacetylase inhibition. Hum Gene Ther. 2013, 24: 295-305.","journal-title":"Hum Gene Ther"},{"key":"4629_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/87757","volume":"2","author":"P Li","year":"2001","unstructured":"Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK: Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol. 2001, 2: 443-451.","journal-title":"Nat Immunol"},{"key":"4629_CR22","doi-asserted-by":"publisher","first-page":"e23348","DOI":"10.1371\/journal.pone.0023348","volume":"6","author":"J Lu","year":"2011","unstructured":"Lu J, Aggarwal R, Kanji S, Das M, Joseph M, Pompili V, Das H: Human ovarian tumor cells escape gammadelta T cell recognition partly by downregulating surface expression of MICA and limiting cell cycle related molecules. PLoS One. 2011, 6: e23348-","journal-title":"PLoS One"},{"key":"4629_CR23","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.4049\/jimmunol.1102237","volume":"188","author":"R Okita","year":"2012","unstructured":"Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R: HER2\/HER3 signaling regulates NK cell mediated cytotoxicity via MHC Class IChain-Related Molecule A and B expression in human breast cancer cell lines. J Immunol. 2012, 188: 2136-2145.","journal-title":"J Immunol"},{"key":"4629_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1083\/jcb.200801169","volume":"182","author":"KF Tang","year":"2008","unstructured":"Tang KF, Ren H, Cao J, Zeng GL, Xie J, Chen M, Wang L, He CX: Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB. J Cell Biol. 2008, 182: 233-239.","journal-title":"J Cell Biol"},{"key":"4629_CR25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/gut.2009.180711","volume":"58","author":"P Fritsche","year":"2009","unstructured":"Fritsche P, Seidler B, Schuler S, Schnieke A, Gottlicher M, Schmid RM, Saur D, Schneider G: HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-onlyprotein NOXA. Gut. 2009, 58: 1399-1409.","journal-title":"Gut"},{"key":"4629_CR26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1182\/blood-2009-11-249474","volume":"116","author":"O Goodyear","year":"2010","unstructured":"Goodyear O, Agathanggelou A, Novitzky-Basso I, Siddique S, McSkeane T, Ryan G, Vyas P, Cavenagh J, Stankovic T, Moss P, Craddock C: Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloidleukemia and myelodysplasia. Blood. 2010, 116: 1908-1918.","journal-title":"Blood"},{"key":"4629_CR27","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1038\/onc.2010.145","volume":"29","author":"RM Hecker","year":"2010","unstructured":"Hecker RM, Amstutz RA, Wachtel M, Walter D, Niggli FK, Schafer BW: p21 Downregulation is an important component of PAX3\/FKHR oncogenicity and itsreactivation by HDAC inhibitors enhances combination treatment. Oncogene. 2010, 29: 3942-3952.","journal-title":"Oncogene"},{"key":"4629_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12032-010-9480-9","volume":"28","author":"X Duan","year":"2011","unstructured":"Duan X, Deng L, Chen X, Lu Y, Zhang Q, Zhang K, Hu Y, Zeng J, Sun W: Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Med Oncol. 2011, 28: 466-474.","journal-title":"Med Oncol"},{"key":"4629_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","volume":"110","author":"C Cerboni","year":"2007","unstructured":"Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A: Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATRdependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 2007, 110: 606-615.","journal-title":"Blood"},{"key":"4629_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nature03884","volume":"436","author":"S Gasser","year":"2005","unstructured":"Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005, 436: 1186-1190.","journal-title":"Nature"},{"key":"4629_CR31","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1093\/brain\/awl205","volume":"129","author":"G Eisele","year":"2006","unstructured":"Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, Weller M, Friese MA: TGF-beta and metalloproteinases differentially suppress NKG2D ligand surfaceexpression on malignant glioma cells. Brain. 2006, 129: 2416-2425.","journal-title":"Brain"},{"key":"4629_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1753","volume":"5","author":"AG Bader","year":"2005","unstructured":"Bader AG, Kang S, Zhao L, Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005, 5: 921-929.","journal-title":"Nat Rev Cancer"},{"key":"4629_CR33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1078-0432.CCR-04-1158","volume":"11","author":"CW Gregory","year":"2005","unstructured":"Gregory CW, Whang YE, McCall W, Fei X, Liu Y, Ponguta LA, French FS, Wilson EM, Earp HS: Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth. Clin Cancer Res. 2005, 11: 1704-1712.","journal-title":"Clin Cancer Res"},{"key":"4629_CR34","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","volume":"113","author":"A Soriani","year":"2009","unstructured":"Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di GV, Cippitelli M, Fionda C, Petrucci MT, Guarini A, Fo\u00e0 R, Santoni A: ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009, 113: 3503-3511.","journal-title":"Blood"},{"key":"4629_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA: Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009, 9: 550-562.","journal-title":"Nat Rev Cancer"},{"key":"4629_CR36","doi-asserted-by":"publisher","first-page":"e31783","DOI":"10.1371\/journal.pone.0031783","volume":"7","author":"N Gao","year":"2012","unstructured":"Gao N, Cheng S, Budhraja A, Liu EH, Chen J, Chen D, Yang Z, Luo J, Shi X, Zhang Z: 3,3\u2032-Diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Aktdependent process. PLoS One. 2012, 7: e31783-","journal-title":"PLoS One"},{"key":"4629_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3892\/ijo.2012.1462","volume":"41","author":"S Miyoshi","year":"2012","unstructured":"Miyoshi S, Hamada H, Hamaguchi N, Kato A, Katayama H, Irifune K, Ito R, Miyazaki T, Okura T, Higaki J: Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo. Int J Oncol. 2012, 41: 449-456.","journal-title":"Int J Oncol"},{"key":"4629_CR38","doi-asserted-by":"publisher","first-page":"e62327","DOI":"10.1371\/journal.pone.0062327","volume":"8","author":"YL Wang","year":"2013","unstructured":"Wang YL, Zhu BJ, Qi ZZ, Wang HJ, Zhou XD: Akt1 Enhances CA916798 Expression through mTOR Pathway. PLoS One. 2013, 8: e62327-","journal-title":"PLoS One"},{"key":"4629_CR39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3892\/or.2012.1827","volume":"28","author":"J Li","year":"2012","unstructured":"Li J, Liang X, Yang X: Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K\/Akt\/NF-kappaB pathways. Oncol Rep. 2012, 28: 501-510.","journal-title":"Oncol Rep"},{"key":"4629_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-09-1324","volume":"16","author":"RJ Kimple","year":"2010","unstructured":"Kimple RJ, Vaseva AV, Cox AD, Baerman KM, Calvo BF, Tepper JE, Shields JM, Sartor CI: Radiosensitization of epidermal growth factor receptor\/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status. Clin Cancer Res. 2010, 16: 912-923.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-370\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:13:43Z","timestamp":1630707223000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4629"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-370","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,25]]},"assertion":[{"value":"24 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"370"}}